PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
27-Apr-2022 North America Outbound Medical Tourism Services Market is estimated to be valued at US$ 150.36 Billion by the end of 2026. MARKITWIRED
27-Apr-2022 Dermal Fillers Market Key Players : Galderma Pharma S.A, Sinclair Pharma plc, Zimmer Biomet Holdings, Allergan plc., Anika Therapeutics Inc. MARKITWIRED
27-Apr-2022 Dermatology Devices Market is expected to be valued at US$ 5,307.6 Million by the end of 2026. MARKITWIRED
27-Apr-2022 North America Vision Care Market is projected to be valued at US$ 100.72 Billion by the end of 2026. MARKITWIRED
27-Apr-2022 Prosthetic Heart Valve Market segment is estimated to be valued at US$ 6,069.1 million by 2026 end MARKITWIRED
27-Apr-2022 Coronary Stents Market Detailed Survey On Key Trends, Leading Players & Revolutionary Opportunities 2026 MARKITWIRED
27-Apr-2022 Vaccine Delivery Systems Is Experiencing A CAGR Of 9.5% Across The 2022-2032 Assessment Period | Fact.Mr Study MARKITWIRED Latest Market Reports
27-Apr-2022 Global OTC Analgesics Market Was Expected To Accelerate At A CAGR Of 5% Through 2031 | Fact.Mr Study C MARKITWIRED Latest Market Reports
27-Apr-2022 Aptamer Market Would Progress At An Impressive Pace, At A CAGR Of 21% | Fact.Mr Study MARKITWIRED Latest Market Reports
27-Apr-2022 Worldwide Cancer Diagnostics Market Is Anticipated To Rise At A Healthy CAGR Of 6% Over The Next Ten Years | Fact.Mr Study MARKITWIRED Latest Market Reports
27-Apr-2022 Global Syringes Was Projected To Witness A CAGR Of 10% During The Forecast Period 2021-2031| Fact.Mr Study MARKITWIRED Latest Market Reports
26-Apr-2022 Concentric Health Experience Named Agency of the Year at the 2022 Manny Awards Newswire
26-Apr-2022 Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022 Legend Capital
26-Apr-2022 2021 financial figures of Vita 34 AG expected to be significantly below market expectations due to several special effects on earnings development Vita 34 AG
26-Apr-2022 Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference Tiziana Life Sciences
26-Apr-2022 Priothera Receives FDA clearance of Investigational New Drug (IND) to start Phase 2b/3 study with mocravimod in Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Priothera
26-Apr-2022 Symeres acquires Organix Inc., adding lipids expertise and a strategic foothold in the US Symeres
26-Apr-2022 Gloucestershire Hospitals NHS Foundation Trust Future-proofs Clinical Pathology Pathway in First of Type Deployment with InterSystems LIMS Gloucestershire Hospitals NHS Foundation Trust
26-Apr-2022 SOTIO Initiates CLAUDIO-01 Trial with Antibody-Drug Conjugate SOT102 in Patients with Gastric and Pancreatic Cancer SOTIO
26-Apr-2022 Sanofi teams up with McLaren Racing to accelerate industrial excellence Sanofi